1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one and Bone Loss, Osteoclastic

1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abe, T; DeAngelis, RA; Hajishengallis, E; Hajishengallis, G; Hosur, KB; Lambris, JD; Maekawa, T; Ricklin, D	1

Other Studies

1 other study(ies) available for 1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one and Bone Loss, Osteoclastic

Article	Year
Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis. Journal of immunology (Baltimore, Md. : 1950), 2014, Jun-15, Volume: 192, Issue:12 Topics: Animals; Bacteroidaceae Infections; Bone Resorption; Complement C3; Disease Models, Animal; Female; Humans; Inflammation Mediators; Macaca fascicularis; Male; Mice; Osteoclasts; Peptides, Cyclic; Periodontitis; Porphyromonas gingivalis; Pyridones	2014

Article

Year

Genetic and intervention studies implicating complement C3 as a major target for the treatment of periodontitis.

Journal of immunology (Baltimore, Md. : 1950), 2014, Jun-15, Volume: 192, Issue:12

Topics: Animals; Bacteroidaceae Infections; Bone Resorption; Complement C3; Disease Models, Animal; Female; Humans; Inflammation Mediators; Macaca fascicularis; Male; Mice; Osteoclasts; Peptides, Cyclic; Periodontitis; Porphyromonas gingivalis; Pyridones

2014